Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 16

1.

Can brain impermeable BACE1 inhibitors serve as anti-CAA medicine?

Li JM, Huang LL, Liu F, Tang BS, Yan XX.

BMC Neurol. 2017 Aug 25;17(1):163. doi: 10.1186/s12883-017-0942-y.

2.

Familial Alzheimer's Disease Mutations within the Amyloid Precursor Protein Alter the Aggregation and Conformation of the Amyloid-β Peptide.

Hatami A, Monjazeb S, Milton S, Glabe CG.

J Biol Chem. 2017 Feb 24;292(8):3172-3185. doi: 10.1074/jbc.M116.755264. Epub 2017 Jan 3.

3.

Potential Pathways for CNS Drug Delivery Across the Blood-Cerebrospinal Fluid Barrier.

Strazielle N, Ghersi-Egea JF.

Curr Pharm Des. 2016;22(35):5463-5476. Review.

4.

Intracerebral haemorrhage in Down syndrome: protected or predisposed?

Buss L, Fisher E, Hardy J, Nizetic D, Groet J, Pulford L, Strydom A.

F1000Res. 2016 May 12;5. pii: F1000 Faculty Rev-876. doi: 10.12688/f1000research.7819.1. eCollection 2016. Review.

5.

Amyloid-β and Astrocytes Interplay in Amyloid-β Related Disorders.

Batarseh YS, Duong QV, Mousa YM, Al Rihani SB, Elfakhri K, Kaddoumi A.

Int J Mol Sci. 2016 Mar 4;17(3):338. doi: 10.3390/ijms17030338. Review.

6.

Cerebral amyloid angiopathy-related infarcts imitating high-grade differentiation of a benign meningioma.

Talarczyk P, Kanodia AK, Ironside J, Mowle D.

BMJ Case Rep. 2015 Sep 17;2015. pii: bcr2015211262. doi: 10.1136/bcr-2015-211262. No abstract available.

7.

Delivery of Polymeric Nanoparticles to Target Vascular Diseases.

Agyare E, Kandimalla K.

J Biomol Res Ther. 2014 Jan;3(1). pii: S1-001.

8.

The overlap between vascular disease and Alzheimer's disease--lessons from pathology.

Attems J, Jellinger KA.

BMC Med. 2014 Nov 11;12:206. doi: 10.1186/s12916-014-0206-2. Review.

9.

Cerebrovascular reactivity to carbon dioxide in Alzheimer's disease.

Glodzik L, Randall C, Rusinek H, de Leon MJ.

J Alzheimers Dis. 2013;35(3):427-40. doi: 10.3233/JAD-122011. Review.

10.

Prolonged diet induced obesity has minimal effects towards brain pathology in mouse model of cerebral amyloid angiopathy: implications for studying obesity-brain interactions in mice.

Zhang L, Dasuri K, Fernandez-Kim SO, Bruce-Keller AJ, Freeman LR, Pepping JK, Beckett TL, Murphy MP, Keller JN.

Biochim Biophys Acta. 2013 Sep;1832(9):1456-62. doi: 10.1016/j.bbadis.2013.01.002. Epub 2013 Jan 9.

11.

Traffic jam at the blood-brain barrier promotes greater accumulation of Alzheimer's disease amyloid-β proteins in the cerebral vasculature.

Agyare EK, Leonard SR, Curran GL, Yu CC, Lowe VJ, Paravastu AK, Poduslo JF, Kandimalla KK.

Mol Pharm. 2013 May 6;10(5):1557-65. doi: 10.1021/mp300352c. Epub 2013 Mar 5.

12.

Cerebral amyloid angiopathy impact on endothelium.

Grinberg LT, Korczyn AD, Heinsen H.

Exp Gerontol. 2012 Nov;47(11):838-42. doi: 10.1016/j.exger.2012.08.005. Epub 2012 Aug 28. Review.

13.

A critical appraisal of experimental intracerebral hemorrhage research.

MacLellan CL, Paquette R, Colbourne F.

J Cereb Blood Flow Metab. 2012 Apr;32(4):612-27. doi: 10.1038/jcbfm.2012.8. Epub 2012 Feb 1. Review.

14.

Vascular β-amyloid and early astrocyte alterations impair cerebrovascular function and cerebral metabolism in transgenic arcAβ mice.

Merlini M, Meyer EP, Ulmann-Schuler A, Nitsch RM.

Acta Neuropathol. 2011 Sep;122(3):293-311. doi: 10.1007/s00401-011-0834-y. Epub 2011 Jun 19.

15.

Neurodegeneration of the retina in mouse models of Alzheimer's disease: what can we learn from the retina?

Chiu K, Chan TF, Wu A, Leung IY, So KF, Chang RC.

Age (Dordr). 2012 Jun;34(3):633-49. doi: 10.1007/s11357-011-9260-2. Epub 2011 May 11. Review.

16.

APP transgenic modeling of Alzheimer's disease: mechanisms of neurodegeneration and aberrant neurogenesis.

Crews L, Rockenstein E, Masliah E.

Brain Struct Funct. 2010 Mar;214(2-3):111-26. doi: 10.1007/s00429-009-0232-6. Epub 2009 Nov 29. Review.

Supplemental Content

Support Center